Progress in Neurotherapeutics and Neuropsychopharmacology

di Cummings • 2008 • dettagli prodotto

spedizione gratuita
normalmente disponibile
per la spedizione in 10-15 giorni lavorativi

da €111,60 a € 106,02

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

Aggiungi al carrello
Aggiungi alla lista dei desideri

DESCRIZIONE

Volumes in this series provide readers with updates of recent clinical trial results in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses. It is an essential update of recent trials in all aspects of the management of neurological and neuropsychiatric disorders.Table of Contents Contributors1. Progress in neurotherapeutics and neuropsychopharmacology Jeffrey L. Cummings2. Trifusal versus aspirin for the prevention of stroke Antonio Culebras, Javier Borja and Julián García-Rafanell3. The Argatroban and tPA stroke study Andrew D. Barreto and James C. Grotta4. Use of Selegiline as monotherapy and in combination with Levodopa in the management of Parkinson's disease: perspectives from the MONOCOMB study Sven E. Pålhagen and Esa Heinonen5. Ropinirole 24-h prolonged release in advanced Parkinson's disease: review of a randomised, double-blind, placebo-controlled study (EASE PD - adjunct study) Kelly E. Lyons and Rajesh Pahwa6. Insulin resistance and Alzheimer's disease: pathophysiology and treatment G. Stennis Watson and Suzanne Craft7. Targeting Amyloid with Tramiprosate in patients with mild-to-moderate Alzheimer's disease P. S. Aisen, R. Briand, D. Saumier, J. Laurin, A. Duong and D. Garceau8. Intranasal Zolmitriptan is effective and well-tolerated in acute cluster headache: a randomized placebo-controlled double-blind crossover study E. Cittadini and P. J. Goadsby9. Optimal dosing of immunomodulating drugs: a dose-comparison study of GA in RRMS Daniel Wynn, Catherine Meyer, Neil Allen and Dennis O'Brien10. Tetrathiomolybdate versus Trientine in the initial treatment of neurologic Wilson's disease George J. Brewer, Fred Askari, Matthew T. Lorincz, Martha Carlson, Michael Schilsky, Karen J. Kluin, Peter Hedera, Paolo Moretti, John K. Fink, Roberta Tankanow, Robert B. Dick and Julia Sitterly11. Randomized clinical trials of Pregabalin for neuropathic pain: methods, results, and implications Robert H. Dworkin, Rajbala Thakur, Teresa Griesing, Uma Sharma and James P. Young12. Effect of Methylphenidate in patients with acute traumatic brain injury: a randomized clinical trial Hossein A. Khalili and Kamyar Keramatian13. Improvement in speeded cognitive processing after anti-epileptic drug withdrawal - a controlled study in mono-therapy patients Erik Hessen, Morten I. Lossius, Ivar Reinvang and Leif Gjerstad14. A randomized-controlled trial of bilateral rTMS for treatment-resistant depression Paul B. Fitzgerald15. Serotonin related genes affect antidepressant treatment in obsessive-compulsive disorder F. Van Nieuwerburgh, D. Deforce and D. A. J. P. Denys16. Night eating syndrome and results from the first placebo-controlled trial of treatment, with the SSRI medication, Sertraline: implications for clinical practice John P. O'Reardon Karen E. Groff, Albert J. Stunkard and Kelly C. Allison17. Modafinil: a candidate for pharmacotherapy of negative symptoms in schizophrenia John H. Peloian and Joseph M. Pierre18. New approaches to treatment of schizophrenia by enhancing N-methyl-D-aspartate neurotransmission Guochuan Emil TsaiSubject indexAuthor index.